Bank Of New York Mellon Corp P Lx Pharma Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.9 - $4.18 $20,168 - $44,370	-10,615 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.69 - $19.66 $446,396 - $1.14 Million	-58,049 Reduced 84.54%	10,615 $85,000
Q3 2021 Nov 12, 2021	BUY	$12.22 - $21.28 $712,743 - $1.24 Million	58,326 Added 564.19%	68,664 $1.33 Million
Q1 2021 May 13, 2021	BUY	$5.24 - $10.14 $54,171 - $104,827	10,338 New	10,338 $93,000

61.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.